A substantial body of research has indicated that the presence and functionality of CD8 + tumor-reactive proliferating T cells, particularly their capacity to modulate IFN-γ immunoregulation within the tumor microenvironment, can markedly impact patient prognosis [10]. This evidence concerns the gene CD8A and neoplasm.